Figures & data
Table 1 Demographic and clinical characteristics of participants with pulmonary hypertension and controls
Figure 1 The increased circulating levels of miR-190a-5p in patients with COPD-PH correlate with disease severity.
Abbreviations: COPD-PH, pulmonary hypertension secondary to chronic obstructive pulmonary disease; CTEPH, chronic thromboembolic pulmonary hypertension; IPAH, idiopathic pulmonary arterial hypertension; KLF15, Krüppel-like factor 15; PAH-CTD, connective tissue disorder-associated pulmonary arterial hypertension; PaO2, partial pressure of arterial oxygen; PH, pulmonary hypertension.
![Figure 1 The increased circulating levels of miR-190a-5p in patients with COPD-PH correlate with disease severity.](/cms/asset/7d045d46-8eea-4287-bca6-43c84d4dd70d/dcop_a_182504_f0001_b.jpg)
Table 2 Cox survival analysis of the COPD-PH cohort
Figure 2 Circulating miR-190a-5p levels have diagnostic and prognostic value in COPD-PH patients.
Abbreviations: COPD-PH, pulmonary hypertension secondary to chronic obstructive pulmonary disease; PH, pulmonary hypertension; ROC, receiver operator characteristic.
![Figure 2 Circulating miR-190a-5p levels have diagnostic and prognostic value in COPD-PH patients.](/cms/asset/c087ce35-b859-430d-a5a5-4235ab7f165a/dcop_a_182504_f0002_c.jpg)
Figure 3 Effects of hypoxia on the levels of miR-190a-5p, KLF15, eNOS, and Arg2 in HPAECs and HPMECs.
Abbreviations: Arg2, Arginase 2; eNOS, endothelial nitric oxide synthase; HPAECs, human pulmonary arterial endothelial cells; HPAFs, human pulmonary artery fibroblasts; HPASMCs, human pulmonary artery smooth muscle cells; HPMECs, human pulmonary microvascular endothelial cells; KLF15, Krüppel-like factor 15; RT-qPCR, real-time quantitative PCR.
![Figure 3 Effects of hypoxia on the levels of miR-190a-5p, KLF15, eNOS, and Arg2 in HPAECs and HPMECs.](/cms/asset/edfabe2e-078f-4674-aee4-615704e2e05c/dcop_a_182504_f0003_b.jpg)
Figure 4 miR-190a-5p correlated with the expression levels of Arg2 and eNOS by targeting KLF15.
Abbreviations: Arg2, Arginase 2; eNOS, endothelial nitric oxide synthase; HPAECs, human pulmonary arterial endothelial cells; KLF15, Krüppel-like factor 15; Mut, mutant; WT, wild type.
![Figure 4 miR-190a-5p correlated with the expression levels of Arg2 and eNOS by targeting KLF15.](/cms/asset/b9006077-3af6-45a9-9c01-935d0c4230d2/dcop_a_182504_f0004_b.jpg)
Figure 5 In vivo effect of antagomir-190a-5p treatment on hemodynamic parameters, right heart hypertrophy, and the expression of KLF15, eNOS, and Arg2 in the hypoxia-induced PAH mouse model.
Abbreviations: Arg2, Arginase 2; eNOS, endothelial nitric oxide synthase; KLF15, Krüppel-like factor 15; NC, negative control; PAH, pulmonary arterial hypertension; RVSP, right ventricular systolic pressure; RV/(LV+S), the ratio of the free wall of the right ventricle weight to the weight of the left ventricle and septum.
![Figure 5 In vivo effect of antagomir-190a-5p treatment on hemodynamic parameters, right heart hypertrophy, and the expression of KLF15, eNOS, and Arg2 in the hypoxia-induced PAH mouse model.](/cms/asset/df032908-a5f1-4dd1-b906-d14ac150d2c8/dcop_a_182504_f0005_c.jpg)